Related Experiment Video
Updated: Jun 12, 2026

11:22
Quantitative Analysis of Alternative Pre-mRNA Splicing in Mouse Brain Sections Using RNA In Situ Hybridization Assay
Published on: August 26, 2018
Distribution of NBCn2 (SLC4A10) splice variants in mouse brain
1Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. liuying@mail.hust.edu.cn
Neuroscience
|June 15, 2010
Summary
Novel antibodies reveal distinct brain region expression patterns for NBCn2 (SLC4A10) splice variants. NBCn2-D is found mainly in the subcortex, while NBCn2-A may dominate in other brain areas.
Area of Science:
- Molecular Biology
- Neuroscience
- Physiology
Background:
- Solute carrier 4 (SLC4) family members, including Na-coupled HCO(3)(-) transporters (NCBTs), are crucial for pH homeostasis and bicarbonate transport.
- The electroneutral Na/HCO(3)(-) cotransporter NBCn2 (SLC4A10), primarily in the brain, exists in multiple splice variants (A, B, C, and a potential D).
- Understanding the tissue-specific expression of NBCn2 splice variants is vital for elucidating its central nervous system functions.
Purpose of the Study:
- To develop novel antibodies for distinguishing NBCn2 splice variants.
- To investigate the expression and distribution of NBCn2 splice variants across different brain regions.
- To confirm the existence and characterize the expression pattern of the NBCn2-D splice variant.
Main Methods:
- Development of three specific rabbit polyclonal antibodies: anti-ABCD (recognizes all variants), anti-BD (recognizes B and D), and anti-CD (recognizes C and D).
- Western blotting analysis to examine NBCn2 splice variant expression in five distinct brain regions (cerebral cortex, subcortex, cerebellum, hippocampus, medulla).
- Immunoprecipitation combined with western blotting to validate the existence and localization of the NBCn2-D variant.
Main Results:
- Distinct expression patterns were observed for NBCn2 variants across brain regions, differing between anti-ABCD and the variant-specific antibodies.
- NBCn2-D was confirmed to exist and is predominantly expressed in the subcortex, with lower levels in the medulla and minimal presence in the cortex, cerebellum, and hippocampus.
- NBCn2-A appears to be the dominant variant in the overall mouse brain, cerebral cortex, cerebellum, and hippocampus. Immunohistochemistry showed high NBCn2 expression in the choroid plexus, cortex, cerebellar molecular layer, hippocampus, and specific brainstem areas.
Conclusions:
- The study successfully generated specific antibodies to differentiate NBCn2 splice variants.
- NBCn2 splice variants exhibit differential regional expression within the brain, suggesting specialized physiological roles.
- NBCn2-D is a newly characterized variant with a distinct subcortical and medullary expression profile, while NBCn2-A is widespread in cortical and cerebellar regions.
Related Concept Videos
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

